Skip to content

Press Releases

Coala Life continues the Swedish cost reduction program and CTO & International Sales and Marketing Director leaves the company

Coala-Life Group AB's CTO, Magnus Samuelsson, and International Sales and Marketing Director, Tomas Tiseus will leave the company as part of the company's cost-reduction program announced autumn 2023. The change has no impact on the US business. They will remain in their positions until the end of December as agreed with the company. About us…

Extraordinary general meeting held in Coala-Life Group AB (publ)

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, JAPAN, CANADA, HONG KONG, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW. At…

Coala Life changes Certified Adviser to Carnegie Investment Bank AB (publ)

Coala Life today announces a change of Certified Adviser from Erik Penser Bank AB to Carnegie Investment Bank AB (publ). Coala Life has entered into an agreement with Carnegie Investment Bank AB (publ) regarding the position as Certified Adviser. Carnegie Investment Bank AB (publ) will take over as Certified Adviser on November 30, 2023. Until…

Coala-Life Group AB quarter three 2023

Third quarter 2023 Net sales increased to SEK 14.1 M (5.0). EBITDA amounted to SEK -30.0 M (-27.8). Operating income totaled SEK -32.3 M (-28.2). Profit after tax was SEK -31.4 M (-18.5). Earnings per share was SEK -0.1 (-0.3). Cash flow from operating activities was SEK -6.4 M (-36.1). The period, January 1, 2023…

NOTICE TO ATTEND AN EXTRAORDINARY GENERAL MEETING IN COALA-LIFE GROUP AB (PUBL)

The shareholders in Coala-Life Group AB (publ) (the “Company”), reg. no. 556495-4682, are hereby given notice to attend an extraordinary general meeting at 10:00 a.m. on Friday 22 December 2023 at Setterwalls Advokatbyrå’s offices at address Sturegatan 10 in Stockholm. The board of directors has decided, pursuant to Chapter 7, Section 4, Paragraph 2 of…

Coala-Life Group AB (publ) proposes upcoming extraordinary general meeting to resolve on a rights issue of approximately SEK 75.4 million and has secured bridge financing

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION FURTHER REQUIRES PROSPECTUS, REGISTRATION, OR OTHER ACTIONS OTHER THAN THOSE UNDER SWEDISH LAW, ARE PROHIBITED, OR OTHERWISE…

Coala Life October monthly KPI´s USA and preliminary figures Q3 2023

Coala Life Group today provides preliminary figures for the quarterly report that will be published on 23 November 2023 as well as key figures for October 2023 Third quarter 2023 Net sales increased to approximately SEK 14 M (5.0). EBITDA amounted to approximately SEK -30 M (-27.8). Operating income totaled approximately SEK -32 M (-28.2).…

Coala Life Key Figures September USA

Key figures for August 2023: Patients in remote monitoring as of September 30, 2023: 4,400 Annualized revenue as of September 30, 2023: $5.0 million Explanations of key figuresPatients in remote monitoring as of September 30, 2023 – The number of patients the company monitored remotely at the end of September.Annualized revenue as of September 30,…

Warrants of series TO 1 exercised to a degree of approximately 45 per cent and Coala Life receives approximately SEK 6.2 million

Coala-Life Group AB (publ) (“Coala Life” or the “Company”) today announces the outcome of the exercise of warrants of series TO 1 (the “Warrants”), which were issued in conjunction with the Company’s rights issue of units during the first quarter of 2023. In total, 74,803,059 Warrants were exercised for the subscription of 24,934,353 new shares…

Coala Life receives subscription commitments and declarations of intent to subscribe through exercise of warrants amounting to approximately SEK 5.6 million

Coala-Life Group AB (publ) (“Coala Life” or the “Company”) has received subscription commitments and declarations of intent to subscribe through exercise of warrants of series TO 1 (the “Warrants”). The subscription commitments and declarations of intent to subscribe amount to approximately SEK 5.6 million in total, corresponding to approximately 40.4 per cent of the Warrants.…

Coala Life August monthly KPI’s USA

KPI’s August 2023: Patients in RPM as of August 31, 2023: 4,400 Annual revenue rate as of August 31, 2023: 5.2 MUSD Explanations of KPI’sPatients in RPM as of August 31, 2023 – Number of patients that the company monitors in USA at the end of August.Annual revenue rate as of August 31, 2023 –…

The exercise period for warrants series TO 1 in Coala-Life begins today

Coala-Life Group AB (publ) (“Coala Life” or the “Company”) issued, in conjunction with a rights issue of units during the first quarter of 2023, a total of 164,979,967 warrants of series TO 1 (the “Warrants”). The exercise period for the Warrants begins today, September 11, 2023, and runs until and including September 22, 2023. Three…

Coala Life reduces the company’s total costs with around 30%

The company is initiating a cost-saving program that will reduce ongoing operating costs while linking sales resources to performance. The program will start immediately and will have an effect already in October 2023. Fully implemented in January 2024, Coala Life's total operating costs will be reduced by approximately 30 percent. The background to the cost…

CEO subscribes for shares in Coala-Life Group AB (publ)

Coala Life's CEO, Dan Pitulia, has subscribed for 10,526,316 shares through a pension insurance on 30 August 2023 for SEK 4 million, with a subscription price of SEK 0.38 per share outside the Nasdaq First North Growth Market. The right to subscribe for the shares was resolved at an extraordinary general meeting on 31 July…

Coala Life’s unique system receives CE-mark according to MDR

Coala Life today proudly announces that its portable ECG solution, Coala Heart Monitor, has been certified as a Class IIa medical device in conformity with the new European Medical Device Regulation 2017/745 (MDR). This is an important milestone for the company and a prerequisite to be able to expand the company's offer in Europe and…

Coala Life’s CFO is leaving the company

Coala-Life Group AB's CFO, Richard Roa, has at his own request chosen to end his employment for new challenges outside the company. Richard Roa will remain in the company's service until the end of September. Coala Life’s controller, Robin Danielsson Källmark, is appointed interim CFO as of September 1. Coala Life has initiated the process…

CEO buys shares in Coala-Life Group AB (publ)

Coala Life's CEO, Dan Pitulia, has acquired 300,000 shares on August 22, 2023 for approximately SEK 0.1 million, with an average price of SEK 0.338 per share on Nasdaq First North Growth Market. About us Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider,…

Coala Life July monthly KPI’s USA

KPI’s July 2023: Patients in RPM as of July 31, 2023: 4,100 Annual revenue rate as of July 31, 2023: 5.0 MUSD Explanations of KPI’sPatients in RPM as of July 31, 2023 – Number of patients that the company monitors in USA at the end of July.Annual revenue rate as of July 31, 2023 –…

Correction: Coala-Life Group AB, quarter two 2023. -Gross profit and subsequent profit measures, SEK 1.4 million better after correction.

Coala Life issues corrections to Coala Life's Quarterly Report Two 2023 published on August 11 and to the press release "Coala-Life Group AB quarter two 2023" with the same publication date. Gross profit and subsequent profit measures, SEK 1.4 million better after correction. The quarterly report contained incorrect information regarding the Group's costs and thus…

Coala-Life Group AB quarter two 2023

Second quarter 2023 Net sales increased to SEK 14.1 M (1.6). EBITDA amounted to SEK -29.8 M (-40.7). Operating income totaled SEK -32.3 M (-41.4). Profit after tax was SEK -29.2 M (-38.5). Earnings per share was SEK -0.1 (-0.6). Cash flow from operating activities was SEK -27.3 M (-50.9). The period, January 1, 2023…

Coala Life is proud to announce certification according to new ISO 27001:2022 standard

Coala Life has passed an independently performed security review through an external audit and received its ISO 27001 re-certification according to the new updated standard of ISO 27001:2022. The ISO (International Organization for Standardization) is an independent, organization that sets global standards for security and safety. ISO 27001, which is part of a family of…

Emma Strömfelt resigns as board member of Coala-Life Group AB (publ)

Emma Strömfelt has informed the Board of Directors of Coala-Life Group AB (publ) that she for personal reasons leaves her position as a Board member with immediate effect. Emma Strömfelt has been a board member of Coala Life since the Annual General Meeting in the spring of 2023. We regret that Emma Strömfelt's time on…

Extraordinary general meeting held in Coala-Life Group AB (publ)

At the extraordinary general meeting in Coala-Life Group AB (publ) (the “Company”) held today, on 31 July 2023, the following resolutions were passed in accordance with the proposals presented in the notice to attend the meeting and the complete proposals kept available on the Company’s website www.coalalife.com. The extraordinary general meeting resolved to: approve of…

The board of directors of Coala-Life Group AB carries out a directed new share issue of SEK 17 million at a 10-day VWAP without discount, subject to the general meeting’s subsequent approval

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END…

NOTICE TO ATTEND AN EXTRAORDINARY GENERAL MEETING IN COALA-LIFE GROUP AB (PUBL)

The shareholders in Coala-Life Group AB (publ) (the “Company”), reg. no. 556495-4682, are hereby given notice to attend an extraordinary general meeting at 10:00 a.m. on Monday 31 July 2023 at Setterwalls Advokatbyrå’s offices at address Sturegatan 10 in Stockholm. The board of directors has decided, pursuant to Chapter 7, Section 4, Paragraph 2 of…

Coala Life June monthly KPI’s USA

KPI’s June 2023: Patients in RPM as of June 30, 2023: 4,100 Annual revenue rate as of June 30, 2023: 5.6 MUSD Explanations of KPI’sPatients in RPM as of June 30, 2023 – Number of patients that the company monitors in USA at the end of June.Annual revenue rate as of June 30, 2023 –…

CEO buys shares in Coala-Life Group AB (publ)

Coala Life's CEO, Dan Pitulia, has acquired 700,000 shares on June 29, 2023 for approximately SEK 0.3 million, with an average price of SEK 0.387 per share on the Nasdaq First North Growth Market. About us Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service…

Coala Life May monthly KPI’s USA

KPI’s May 2023: Patients in RPM as of May 31, 2023: 3,800 Annual revenue rate as of May 31, 2023: 5.7 MUSD Explanations of KPI’sPatients in RPM as of May 31, 2023 – Number of patients that the company monitors in USA at the end of May.Annual revenue rate as of May 31, 2023 –…

Coala Heart Monitor as part of digital venture in remote patient monitoring

Stockholm Regional Council will be starting an effort to investigate digital devices in remote patient monitoring this year. Coala Life is one of three partners selected to participate in this pilot project. Around 50 of the patients included in the study have heart conditions, such as atrial fibrillation, and are monitored digitally from their homes.…

Coala Life April monthly KPI’s USA

KPI’s April 2023: Patients in RPM as of April 30, 2023: 3,700 Annual revenue rate as of April 30, 2023: 5.4 MUSD Explanations of KPI’sPatients in RPM as of April 30, 2023 – Number of patients that the company monitors in USA at the end of April.Annual revenue rate as of April 30, 2023 –…

Bulletin from annual general meeting in Coala-Life Group AB (publ) on 16 May 2023

Coala-Life Group AB (publ) (the “Company” or “Coala-Life”) has held an annual general meeting on 16 May 2023. Below follows a summary of the decisions taken by the annual general meeting (all in accordance with the proposals presented in the notice to attend the meeting kept available at the Company’s website www.coalalife.com). The annual general…

Coala-Life Group AB quarter one 2023

First quarter 2023 Net sales increased to SEK 11.6 M (1.0). EBITDA amounted to SEK -32.2 M (-30.5). Operating income totaled SEK -33.9 M (-31.6). Profit after tax was SEK -35.1 M (-31.4). Earnings per share (weighted) was SEK -0.3 (-0.9). Cash flow from operating activities was SEK -31.3 M (-35.4). Events in the quarter…

Annual Report 2022 – Coala-Life Group AB (publ)

Coala-Life Group AB´s annual report for 2022 is available from today on the company´s website www.coalalife.com. Coala-Life Group AB hereby publishes its annual report for 2022. The annual report is available as an attached file or available on the company's website: https://investors.coalalife.com/sv/investerare/finansiella-rapporter-och-presentationer/ About us Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015,…

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN COALA-LIFE GROUP AB (PUBL)

The shareholders in Coala-Life Group AB (publ), reg. no. 556495-4682, are hereby given notice to attend the annual general meeting at 10:00 a.m. on Tuesday 16 May 2023 at Setterwalls Advokatbyrå’s offices at address Sturegatan 10 in Stockholm. Registration for the meeting commences 30 minutes before the opening of the meeting. The board of directors…

Coala Life March monthly KPI’s USA

KPI’s March 2023: Patients in RPM as of March 31, 2023: 3,700 Annual revenue rate as of March 31, 2023: 4.8 MUSD Explanations of KPI’sPatients in RPM as of March 31, 2023 – Number of patients that the company monitors in USA at the end of March.Annual revenue rate as of March 31, 2023 –…

Coala-Life Group AB Interim Report January – December 2022

Fourth quarter 2022 Net sales increased to SEK 9.3 M (1.0). EBITDA amounted to SEK -42.9 M (-118.0). Operating income totaled SEK -46.1 M (-120.5). Profit after tax was SEK -53.4 M (-111.0). Earnings per share (weighted) was SEK -0.8 (-6.3). Cash flow from operating activities was SEK -32.0 M (-24.7). The period, January 1,…

Coala Life February monthly KPI’s USA

KPI’s February 2023: Patients in RPM as of February 28, 2023: 3,700 Annual revenue rate as of February 28, 2023: 4.6 MUSD Explanations of KPI’sPatients in RPM as of February 28, 2023 – Number of patients that the company monitors in USA at the end of February.Annual revenue rate as of February 28, 2023 –…

Coala-Life Group AB (publ) announces last day of trading in BTUs and first day of trading in new shares and warrants

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, JAPAN, CANADA, HONG KONG, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW. The…

Coala-Life Group AB (publ) announces outcome of completed rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, JAPAN, CANADA, HONG KONG, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW Coala-Life…

New published study validating diagnostic accuracy of Coala Heart Monitor

Non-invasive Coala Heart Monitor has been validated for diagnostic accuracy, compared to reference standard 12-lead-electrocardiogram, to help detect atrial tachyarrhythmia and atrial fibrillation. Coala Life, an innovative Swedish medical device company offering remote patient monitoring solutions, today announce the results of yet another study validating the use of Coala Heart Monitor. In this validation study,…

Coala-Life Group publishes supplement to prospectus in respect of ongoing rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, JAPAN, CANADA, HONG KONG, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW. Coala-Life…

Coala Life January monthly KPI’s USA

KPI’s January 2023: Patients in RPM as of January 31, 2023: 3,800 Annual revenue rate as of January 31, 2023: 3.7 MUSD Explanations of KPI’sPatients in RPM as of January 31, 2023 – Number of patients that the company monitors in USA at the end of January.Annual revenue rate as of January 31, 2023 –…

Coala-Life Group AB (publ) expands guarantee consortium in the ongoing rights issue and updates estimated transaction costs

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, JAPAN, CANADA, HONG KONG, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW. Coala-Life…

Coala-Life Group publishes prospectus in connection with rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, JAPAN, CANADA, HONG KONG, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW. Coala-Life…

Tomorrow, the subscription period in Coala-Life’s rights issue, begins. Subscription undertakings and guarantee commitments amounts to approx. 76.5% of the issue, corresponding to approx. SEK 77.6M.

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, CANADA, HONG KONG, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW. Tomorrow, February…

Extraordinary general meeting held in Coala-Life Group AB (publ)

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, JAPAN, CANADA, HONG KONG, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE ANY OTHER MEASURES THAN REQUIRED BY SWEDISH LAW. At…

Coala Life December monthly KPI’s USA

KPI’s December 2022: Patients in RPM as of December 31, 2022: 3,500 Annual revenue rate as of December 31, 2022: 3.6 MUSD Explanations of KPI’sPatients in RPM as of December 31, 2022 – Number of patients that the company monitors in USA at the end of December.Annual revenue rate as of December 31, 2022 –…